SMTL ID : 5uis.2 (3 other biounits)

Crystal structure of IRAK4 in complex with compound 12

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 8C1: 4-{[(3R)-piperidin-3-yl]oxy}-6-[(propan-2-yl)oxy]quinoline-7-carboxamide(Non-covalent)

8C1.1: 20 residues within 4Å: Chain A: M.55, G.56, E.57, G.58, V.63, A.74, K.76, V.109, Y.125, V.126, Y.127, M.128, G.131, S.132, D.135, A.178, N.179, L.181, S.191, D.192 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.63, A:V.109, A:Y.125, A:Y.125, A:L.181 Hydrogen bonds: A:V.126, A:M.128 Water bridges: A:N.179

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lee, K.L. et al., Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design. J. Med. Chem. (2017)

Release Date

2017-05-24

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence